Although previous preclinical studies have mostly focused on TNBC, we observed that ERβ was expressed (both RNA and protein level) in ERα+ breast cancer cell lines at levels that were not significantly different from those in TNBC cell lines (Figures 1A–C). This evidence concerns the gene ESR2 and breast carcinoma.